HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Xuan Sun Selected Research

CVT 313

11/2021A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Xuan Sun Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2018
1Hepatocellular Carcinoma (Hepatoma)
11/2021
1Neoplasms (Cancer)
11/2021
1Hypoglycemia (Reactive Hypoglycemia)
10/2018

Drug/Important Bio-Agent (IBA)

2Insulin (Novolin)FDA Link
01/2020 - 10/2018
1Gefitinib (Iressa)FDA Link
11/2021
1cinobufaginIBA
11/2021
1chan su (ChanSu)IBA
11/2021
1CVT 313IBA
11/2021
1Proteoglycans (Proteoglycan)IBA
11/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021

Therapy/Procedure

2Therapeutics
11/2021 - 10/2018
1Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021
1Glycemic Control
10/2018